Skip to main content

Advertisement

Table 5 Beliefs influencing patients' likelihood of accepting enfuvirtide if offered to them by their physician

From: Prescribing and using self-injectable antiretrovirals: How concordant are physician and patient perspectives?

  Likelihood of accepting enfuvirtide
  Likely a Moderately likely b Unlikely c
  (n = 180) (n = 214) (n = 122)
  Mean (SD) Mean (SD) Mean (SD)
Perception that enfuvirtide is more effective and preferable to oral therapy
(F [2502] = 102.5, p < 0.001)
4.39 (1.26) 3.34 (1.08) 2.53 (0.91)
Perceived barriers to adherence
(F [2503] = 77.26, p < 0.001)
2.45 (1.20) 3.52 (1.27) 4.27 (1.37)
Concerns about self injecting
(F [2513] = 36.0, p < 0.001)
2.65 (1.14)* 3.29 (1.08)* 3.74 (1.18)
Resistance to doctor recommending self-injectable therapies
(F [2513] = 72.2, p < 0.001)
1.90 (1.12) 2.95 (1.35) 3.76 (1.61)
Perception that doctors have positive views about enfuvirtide
(F [2233] = 8.66, p < 0.001)
1.57 (0.50) 1.35 (0.48) 1.23 (0.42)
  1. a, b, c: refer to the product profile (Figure 1) preference score. Patients responded to the question, "If you were offered this product by your physician, how likely would you be to accept it?" using ratings of a1–3, b4, and c5–7 on a 7-point scale, where 1 is 'very likely', 4 is a neutral opinion, and 7 is 'not likely at all.'
  2. All comparisons p < 0.001 except for *p < 0.005.